A Less Debilitating Approach to Cancer Diagnosis

New method combines X-ray imaging and radar

05-Aug-2025
© Fraunhofer EMI

Setting up for CT measurement of a breast surface phantom

imaging methods are an essential part of medicine, used in everything from diagnosis and treatment to follow-up examinations. X-ray mammography dominates the field of early detection of breast cancer, providing rapid and accurate two-dimensional images. Three-dimensional computed tomography (CT) is used in cancer diagnosis, but because it involves high doses of radiation, it poses health risks of its own. While a person’s natural annual radiation exposure is about 2.1 millisieverts, a chest CT involves about three times as much. In the MultiMed project, which explores multimodal medical imaging in 3D, Fraunhofer researchers are developing a method that combines X-ray imaging and radar. It is not only expected to improve the accuracy and efficacy of diagnosing, monitoring and treating breast and lung cancer but also lighten the burden on patients.

Radar in medicine: an outsider with potential

Radar is established in many areas: Airports use it to monitor air traffic, and radar sensors are a part of automotive assistance systems. In medicine, however, this method has been more of an outsider so far. And yet, it too can supply three-dimensional images — without posing any health risks. Radar does have lower resolution, plus it cannot penetrate as deep when compared to other methods. But it provides material information that other processes cannot offer directly. Radar detects differences in electrical permittivity and conductivity, so it can be used to identify changes in tissue.

The challenge lies in combining the types of measurements taken by the two methods. The researchers are developing special ways of linking the imaging data from the two systems together. Called “co-registering,” this approach sets the radar and X-ray data in spatial relation to each other.

To further enhance image quality and visualize interior areas of the body in three dimensions via radar, the researchers are working on new radar reconstruction algorithms. This will unlock sharper images and more detailed insight into tissue properties.

At the same time, X-ray CT reconstruction is also being optimized: Radar data is being incorporated into the X-ray reconstruction to produce a multimodal CT algorithm. This enhances the quality and level of detail of the CT images, reduces disruptive artifacts and lowers radiation exposure.

The research team has already developed initial imaging phantoms to test this method. Phantoms like these are artificial models that realistically simulate tissue structures, supplying suitable signals for radar and X-ray measurements.

Goal: detect tissue changes early on, accurately and with low radiation

The three-year project is intended to result in a multimodal lab system. This testing and development environment will combine CT imaging using X-rays with radar imaging to provide more comprehensive and accurate analyses. “The new approach has the potential to detect tissue changes early on and with great accuracy — and with much less of a burden on patients than before,” says project manager Victoria Heusinger-Hess from the Fraunhofer Institute for High-Speed Dynamics, Ernst-Mach-Institut, EMI.

The Fraunhofer-Gesellschaft is funding the three-year research project. Under the leadership of Fraunhofer EMI, the Fraunhofer Institute for Digital Medicine MEVIS and the Fraunhofer Institute for High Frequency Physics and Radar Techniques FHR are also involved.

Other news from the department science

Most read news

More news from our other portals

So close that even
molecules turn red...

Last viewed contents

An advanced imaging technique detects cancer with unprecedented precision - New endoscopy technology enables early detection of esophageal cancer

An advanced imaging technique detects cancer with unprecedented precision - New endoscopy technology enables early detection of esophageal cancer

Dana-Farber Cancer Institute unveils groundbreaking blood test for multiple myeloma

Dana-Farber Cancer Institute unveils groundbreaking blood test for multiple myeloma

Milestone for medical research: New method enables comprehensive identification of omega fatty acids - Researchers at the University of Graz and the University of California, San Diego present an effective method to determine omega positions of lipids in complex biological samples including human tissues and blood

Milestone for medical research: New method enables comprehensive identification of omega fatty acids - Researchers at the University of Graz and the University of California, San Diego present an effective method to determine omega positions of lipids in complex biological samples including human tissues and blood

Humify – superfood for the soil - Fighting climate change with green chemistry: The start-up Humify has developed a technology that can reactivate soil as a carbon sink

Humify – superfood for the soil - Fighting climate change with green chemistry: The start-up Humify has developed a technology that can reactivate soil as a carbon sink

BINDER acquires Parameter Generation & Control

BINDER acquires Parameter Generation & Control

Sanofi to acquire biotech start-up Vicebio - Expanding respiratory vaccines pipeline

Sanofi to acquire biotech start-up Vicebio - Expanding respiratory vaccines pipeline

Where science powers start-ups - New biotech hub BioLabs|TUM launched to foster start-ups

Where science powers start-ups - New biotech hub BioLabs|TUM launched to foster start-ups

Labguru and Titian Software Rebrand as Cenevo - Cenevo brings together lab management systems Labguru and Mosaic to unlock the full potential of labs and accelerate scientific discovery

Labguru and Titian Software Rebrand as Cenevo - Cenevo brings together lab management systems Labguru and Mosaic to unlock the full potential of labs and accelerate scientific discovery

€12M for LIfT BioSciences: Breakthrough in Cancer Therapy? - The grant from Ireland's Disruptive Technologies Innovation Fund will support the first-in-human clinical trial of LIfT's IMAN therapy

€12M for LIfT BioSciences: Breakthrough in Cancer Therapy? - The grant from Ireland's Disruptive Technologies Innovation Fund will support the first-in-human clinical trial of LIfT's IMAN therapy

Bayer posts positive second quarter and progress on strategic priorities

Bayer posts positive second quarter and progress on strategic priorities

Merck Delivers Profitable Organic Growth Amid Strong Currency Headwinds - Strong sales in Process Solutions and for blockbusters Mavenclad and Erbitux, sustained demand for Semiconductor Materials

Merck Delivers Profitable Organic Growth Amid Strong Currency Headwinds - Strong sales in Process Solutions and for blockbusters Mavenclad and Erbitux, sustained demand for Semiconductor Materials

Head-to-head against AI, pharmacy students won - A study showed that when compared with students, ChatGPT 3.5 was less likely to correctly answer questions on therapeutics exams focused on clinical applications and cases.

Head-to-head against AI, pharmacy students won - A study showed that when compared with students, ChatGPT 3.5 was less likely to correctly answer questions on therapeutics exams focused on clinical applications and cases.